Resistant Hypertension in the age of SPRINT and Pathway2

Resistant Hypertension in the age of SPRINT and Pathway2

Susan P Steigerwalt, M.D., FACP, FASH and associate clinical professor of Cardiovascular Medicine, presents on Resistant Hypertension in the age of SPRINT and Pathway2. Resistant hypertension is a common medical disorder, defined as the failure to achieve goal blood pressure despite three different antihypertensive medications at full dosages, one of which is a diuretic. 


Created by

Colleague Connection

Related Presenters

Susan Steigerwalt, MD

Susan Steigerwalt, MD

Associate Professor

My research focuses on hypertension and cardiovascular outcomes in chronic kidney disease (CKD), and I have developed substantial expertise in ABPM and non-invasive arterial assessment as a site Principal Investigator for the NIDDK-funded ...

View full profile